Insider Trading activities of Hemispherx Biopharma Inc (HEB)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Hemispherx Biopharma Inc (HEB) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Hemispherx Biopharma Inc since year 2005. Table 2 shows the detailed insider transactions of Hemispherx Biopharma Inc since 2005. The reporting company's ticker symbol is HEB. The reporting company's CIK number is 946644.
The total value of stock buying since 2005 is $2,632,905.
The total value of stock sales since 2005 is $316,221.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Hemispherx Biopharma Inc (HEB).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-06 67,777 $274,033 0 $0 0 $0
2019-03 13,400 $2,358 0 $0 0 $0
2018-11 45,238 $9,392 0 $0 0 $0
2018-10 103,500 $20,710 0 $0 0 $0
2018-07 337,905 $104,060 0 $0 0 $0
2018-04 132,000 $42,240 0 $0 0 $0
2017-05 55,556 $34,997 0 $0 0 $0
2017-04 272,464 $150,000 0 $0 0 $0
2017-02 24,887 $11,447 0 $0 0 $0
2016-12 68,493 $49,999 0 $0 0 $0
2016-11 10,000 $10,000 0 $0 0 $0
2016-08 15,750 $34,807 0 $0 0 $0
2016-07 104,000 $12,328 0 $0 0 $0
2016-06 115,000 $13,800 0 $0 0 $0
2016-03 100,000 $15,210 0 $0 0 $0
2015-08 154,104 $27,838 0 $0 0 $0
2015-04 600,000 $141,999 0 $0 0 $0
2012-05 50,000 $12,749 0 $0 0 $0
2011-03 50,000 $23,000 0 $0 0 $0
2010-08 822,286 $407,866 377,388 $187,136 0 $0
2010-07 3,450 $1,746 0 $0 0 $0
2010-06 1,114,469 $689,658 221,798 $129,085 0 $0
2009-12 47,377 $27,067 0 $0 0 $0
2008-09 28,500 $9,975 0 $0 0 $0
2006-12 95,600 $206,867 0 $0 0 $0
2005-11 29,000 $68,295 0 $0 0 $0
2005-08 10,000 $15,200 0 $0 0 $0
2005-06 29,209 $56,048 0 $0 0 $0
2005-04 61,631 $92,225 0 $0 0 $0
2005-03 47,500 $66,991 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Hemispherx Biopharma Inc insiders (HEB)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-06-27 Equels Thomas K. (Exec. Vice Chairman/CEO/Pres.) Buy 2,632 4.37 11,501
2019-06-21 Appelrouth Stewart (Director) Buy 9,677 4.03 38,998
2019-06-21 Rodino Iii Peter W. (Dir Govt Relations/Sectry) Buy 8,695 4.03 35,040
2019-06-21 Springate Wayne S (Sr. VP of Operations) Buy 5,211 4.03 21,000
2019-06-21 Equels Thomas K. (Exec. Vice Chairman/CEO/Pres.) Buy 29,404 4.03 118,498
2019-06-21 Strayer David R (Chief Science/Medical Officer) Buy 2,481 4.03 9,998
2019-06-21 Mitchell William M (Director) Buy 9,677 4.03 38,998
2019-03-19 Equels Thomas K. (Exec. Vice Chairman/CEO/Pres.) Buy 13,400 .18 2,358
2018-11-30 Equels Thomas K. (Exec. Vice Chairman/CEO/Pres.) Buy 20,000 .19 3,840
2018-11-05 Appelrouth Stewart (Director) Buy 25,238 .22 5,552
2018-10-26 Equels Thomas K. (Exec. Vice Chairman/CEO/Pres.) Buy 3,500 .20 710
2018-10-25 Equels Thomas K. (Exec. Vice Chairman/CEO/Pres.) Buy 100,000 .20 20,000
2018-07-27 Equels Thomas K. (Exec. Vice Chairman/CEO/Pres.) Buy 34,483 .29 10,000
2018-07-24 Appelrouth Stewart (Director) Buy 126,000 .31 39,060
2018-07-23 Pascale Adam (CFO) Buy 32,259 .31 10,000
2018-07-23 Springate Wayne S (Sr. VP of Operations) Buy 32,259 .31 10,000
2018-07-23 Equels Thomas K. (Exec. Vice Chairman/CEO/Pres.) Buy 112,904 .31 35,000
2018-04-27 Appelrouth Stewart (Director) Buy 100,000 .32 32,000
2018-04-27 Equels Thomas K. (CEO, President) Buy 32,000 .32 10,240
2017-05-02 Pascale Adam (CFO) Buy 15,873 .63 9,999
2017-05-02 Rodino Peter W. Iii (Exec Dir Govt Relations/Secrty) Buy 15,873 .63 9,999
2017-05-02 Springate Wayne S. (Sr VP of Operations) Buy 15,873 .63 9,999
2017-05-02 Strayer David R (Chief Science/Medical Officer) Buy 7,937 .63 5,000
2017-04-27 Equels Thomas K. (CEO, President) Buy 72,464 .69 50,000
2017-04-11 Equels Thomas K. (CEO, President) Buy 200,000 .50 100,000
2017-02-16 Pascale Adam (CFO) Buy 6,981 .46 3,211
2017-02-16 Springate Wayne S. (Sr VP of Operations) Buy 8,014 .46 3,686
2017-02-16 Strayer David R (Chief Science/Medical Officer) Buy 9,892 .46 4,550
2016-12-22 Equels Thomas K. (CEO, President) Buy 68,493 .73 49,999
2016-11-01 Equels Thomas K. (CEO,President) Buy 10,000 1.00 10,000
2016-08-24 Appelrouth Stewart (Director) Buy 15,750 2.21 34,807
2016-07-08 Equels Thomas K. (CEO, President) Buy 48,000 .12 5,664
2016-07-01 Equels Thomas K. (CEO,President) Buy 56,000 .12 6,664
2016-06-30 Equels Thomas K. (CEO,President) Buy 56,000 .12 6,720
2016-06-29 Equels Thomas K. (CEO,President) Buy 59,000 .12 7,080
2016-03-18 Equels Thomas K. (CEO,Pres,Exec Vice Chairman) Buy 30,000 .13 3,960
2016-03-11 Equels Thomas K. (CEO,Pres,Exec Vice Chairman) Buy 40,000 .16 6,360
2016-03-10 Equels Thomas K. (CEO,Pres,Exec Vice Chairman) Buy 30,000 .16 4,890
2015-08-20 Carter William A (CEO) Buy 25,000 .18 4,500
2015-08-18 Carter William A (CEO) Buy 25,000 .18 4,550
2015-08-17 Carter William A (CEO) Buy 25,000 .18 4,550
2015-08-14 Equels Thomas K. (CFO, Pres.,Sec., Vice Chairman) Buy 50,000 .18 9,000
2015-08-13 Equels Thomas K. (CFO, Pres.,Sec., Vice Chairman) Buy 29,104 .18 5,238
2015-04-28 Carter William A (CEO) Buy 100,000 .24 24,200
2015-04-27 Equels Thomas K. (CFO, Vice Chairman, Secretary) Buy 100,000 .24 24,400
2015-04-21 Carter William A (CEO) Buy 100,000 .24 24,000
2015-04-20 Equels Thomas K. (CFO, Vice Chairman, Secretary) Buy 100,000 .24 23,900
2015-04-17 Carter William A (CEO) Buy 73,681 .23 16,946
2015-04-16 Carter William A (CEO) Buy 26,319 .23 6,053
2015-04-15 Equels Thomas K. (CFO, Vice Chairman, Secretary) Buy 100,000 .23 22,500
2012-05-18 Strayer David R (Other) Buy 44,900 .26 11,449
2012-05-17 Strayer David R (Other) Buy 5,100 .26 1,300
2011-03-01 Lander Russel J (VP of Process/QualityAssurance) Buy 50,000 .46 23,000
2010-08-23 Lander Russel J (VP of Process/QualityAssurance) Buy 1,460 .51 737
2010-08-11 Carter William A (CEO) Sale 26,519 .48 12,755
2010-08-10 Carter William A (CEO) Buy 820,826 .50 407,129
2010-08-10 Carter William A (CEO) Sale 350,869 .50 174,381
2010-07-23 Lander Russel J (VP of Process/QualityAssurance) Buy 2,500 .52 1,300
2010-07-16 Lander Russel J (VP of Process/QualityAssurance) Buy 950 .47 446
2010-06-23 Strayer David R (Other) Sale 50,648 .55 27,856
2010-06-22 Strayer David R (Other) Sale 252 .56 141
2010-06-16 Strayer David R (Other) Buy 230,586 .57 132,586
2010-06-15 Springate Wayne S. (Vice President of Operations) Buy 185,748 .59 109,777
2010-06-15 Springate Wayne S. (Vice President of Operations) Sale 83,104 .59 49,114
2010-06-15 Bernhardt Charles Thomas Iii (Chief Financial Officer) Buy 198,135 .59 117,295
2010-06-15 Bernhardt Charles Thomas Iii (Chief Financial Officer) Sale 87,794 .59 51,974
2010-06-11 Carter William A (CEO) Buy 500,000 .66 330,000
2009-12-15 Springate Wayne S. (Other) Buy 877 .56 492
2009-12-08 Dickey Robert Iv (Senior Vice President) Buy 2,500 .64 1,600
2009-12-07 Bernhardt Charles Thomas Iii (CFO) Buy 2,000 .56 1,126
2009-12-07 Strayer David R (Other) Buy 12,000 .56 6,779
2009-12-07 Carter William A (CEO) Buy 30,000 .57 17,070
2008-09-25 Strayer David R (Other) Buy 28,500 .35 9,975
2006-12-06 Piani Richard (Director) Buy 25,000 2.36 59,000
2006-12-05 Spence Steven D (Director) Buy 48,100 2.15 103,222
2006-12-01 Bonelli Anthony (President & COO) Buy 2,500 1.97 4,925
2006-12-01 Carter William A (Chief Executive Officer) Buy 20,000 1.99 39,720
2005-11-29 Spence Steven D (Director) Buy 29,000 2.35 68,295
2005-08-18 Spence Steven D (Director) Buy 10,000 1.52 15,200
2005-06-17 Spence Steven D (Director) Buy 14,509 1.94 28,074
2005-06-10 Spence Steven D (Director) Buy 14,700 1.90 27,974
2005-04-14 Strayer David R (Medical Director) Buy 2,000 1.39 2,780
2005-04-01 Spence Steven D (Director) Buy 39,754 1.50 59,630
2005-03-30 Mitchell William M (Director) Buy 4,000 1.42 5,680
2005-03-28 Peterson Robert E (Chief Financial Officer) Buy 7,500 1.51 11,362
2005-03-24 Piani Richard (Director) Buy 11,000 1.40 15,399
2005-03-23 Etheridge Ransom (Director) Buy 10,000 1.31 13,100
2005-03-21 Carter William A (CEO) Buy 15,000 1.43 21,450

Insider trading activities including stock purchases, stock sales, and option exercises of HEB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Hemispherx Biopharma Inc (symbol HEB, CIK number 946644) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month